Yicha - HUTCHMED Initiates Phase I Trial of Anti-CD47 Monoclonal Antibody HMPL-A83 in Patients with Advanced Malignant Neoplasms in China

Article: https://www.marketscreener.com/quote/stock/HUTCHMED-CHINA-LIMITED-26786463/news/HUTCHMED-Initiates-Phase-I-Trial-of-Anti-CD47-Monoclonal-Antibody-HMPL-A83-in-Patients-with-Advanced-40991094/?utm_medium=RSS&utm_content=20220715